SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001485003-20-000026
Filing Date
2020-02-26
Accepted
2020-02-26 17:21:13
Documents
1
Period of Report
2020-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158275565627269.html 4  
1 FORM 4 wf-form4_158275565627269.xml 4 3860
  Complete submission text file 0001485003-20-000026.txt   5360
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TREVENA, INC. 1018 WEST 8TH AVENUE, SUITE A KING OF PRUSSIA PA 19406
Business Address
Bourdow Carrie L. (Reporting) CIK: 0001638989 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 20657212